GLP-1 Dosing Calculator

GLP-1 (glucagon-like peptide-1) receptor agonists are injectable medications that mimic a natural hormone to help regulate blood sugar and appetite. They slow stomach emptying, increase feelings of fullness, and are FDA-approved for type 2 diabetes and/or chronic weight management depending on the specific drug.

All GLP-1 medications start at a low dose and gradually increase over weeks to months. This titration period helps your body adjust and significantly reduces the risk of gastrointestinal side effects like nausea, vomiting, and diarrhea. Skipping ahead to higher doses is not recommended by prescribing guidelines.

Semaglutide (Wegovy, Ozempic) targets only the GLP-1 receptor. Tirzepatide (Zepbound, Mounjaro) is a dual agonist that targets both GLP-1 and GIP receptors, which may provide additional benefits for blood sugar control and weight loss. Both are administered as once-weekly injections. Your doctor can help determine which is the best fit for your situation.

No. Federal law prohibits the use of manufacturer copay cards or savings programs with government-funded insurance, including Medicare, Medicaid, Tricare, and VA benefits. These savings programs are only available to patients with eligible commercial (private) insurance. Some manufacturers offer separate patient assistance programs for low-income or government-insured patients.

The estimates are based on publicly available pricing data researched in April 2026 and are intended to give you a general sense of cost ranges. Actual prices vary by pharmacy, geographic location, specific plan formulary, deductible status, and whether manufacturer programs apply. Always confirm pricing with your pharmacy and insurance provider before making decisions.